The Prognosis of Patients Operated on for Gastric Cancer in Relation to the Percentage of Lymph Nodes Invaded by Tumour

References

• Feig B.W., Berger D.H., Fuhrman G. M. The M.D. Anderson Surgical Oncology Handbook. Third edition. Philadelphia: Lippincott Williams & Wilkins, 2003.
   Google Scholar
• Hunt R. H. Will eradication of helicobacter pylori infection influence the risk of gastric cancer ? Am J Med, 2004, 7 Suppl 5A: 86S-91S .
   Google Scholar
• Coniglio A., Tiberio G. A., Busti M., Gaverini G., Baiocchi L., Piardi T., Ronconi M., Giulini S. M. Surgical treatment for gastric carcinoma in the elderly. J Surg Oncol, 2004, 88: 201205.
   Google Scholar
• Usui S., Inoue H., Yoshida T., Fukami N., Kudo S., Iwai T. Handassisted laparascopic total gastrectomy for early gastric cancer. Surg Laparosc Endose Percutan Tech, 2003, 13: 304–7.
   Google Scholar
• Tanaka K., Tonouchi H., Kobayashi M., Konishi N., Ohmori Y., Mohri Y., Kusunoki M. Laparascopically assisted total gastrectomy with sentinel node biopsy for early gastric cancer: preliminary results. Am Am Surg, 2004, 70: 976–81.
   Google Scholar
• Ryu K., Lee J., Kim H., Kim Y., Choi I., Bae J. Prediction of lymph node metastasis by sentinel node biopsy in gastric cancer. Eur J Surg Oncol, 2003, 29: 895–9.
   Google Scholar
• Bouche O., Raoul J., Bonnetain F., Giovanni M., Etienne P., Lledo G., Arsene D., Paitel J., Guerin-Meyer V., Mitry E., Buecher B., Kaminsky M., Seitz J., Rougier P., Bedenne L., Milan C. A randomised multi-centre phase trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study - FFCD 9803. J Clin Oncol, 2004, 22: 4319–28.
   Google Scholar
• Popiela T., Kulig J., Czupryna A., Szczepanik A., Zembala M. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer, 2004, 7: 240–5.
   Google Scholar
• Wagner A. D., Grothe W., Behl S. et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev, 2005, 2: CD004046.
   Google Scholar
• Xu D., Zhan Y., Sun X., Cao S., Geng Q. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastro-enterology, 2004, 10: 2727–30.
   Google Scholar
• Adachi Y., Kamakura T., Mori M., Maehara Y., Sugimachi K. The role of lymph node dissection and splenectomy in node positive gastric carcinoma. Surgery, 1994, 116: 837–41.
   Google Scholar
• Bonenkamp J. J., Bunt A. M. G., Van de Velde C. J. H., Sasako M., Boon M. C. Radical lymphadenectomy for gastric cancer. A prospective randomised trial in the Netherlands. Surg Oncol Clin NAm, 1993, 2: 443–58.
   Google Scholar
• Smith J. W., Shiu M. K., Kelsey L., Brennam M. F. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg, 1991, 126: 1469–73..
   Google Scholar
• Kenyukai I. et al. Japanese classification of gastric carcinoma. Japanese research Society for gastric cancer. 1st English edition. Tokyo: Kanehara & co, 1995.
   Google Scholar
• Kodama Y., Sugimachi K., SoEJiMA K. et al. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg, 1981, 5: 241–248.
   Google Scholar
• Bonenkamp J. J., Songun I., Hermans J. et al. A randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. The Lancet, 1995, 345: 745–748.
   Google Scholar
• Bonenkamp J. J., Hermans J., Sasako M. et al. Extended lymph node dissection for gastric cancer. Dutch Gastric Cancer Group. NEngl J Med, 1999, 340: 908–914.
   Google Scholar
• Cuschieri A., Fayers P., Fielding J. et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Lancet, 1996, 347: 995–999.
   Google Scholar
• Cuschieri A., Weeden S., Fielding J. et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomised surgical trial. Brit J of Cancer, 1999, 79: 15221530.
   Google Scholar
• Fleming I. D., Cooper J. S., Henson D. E. et al. editors. Manual for staging of cancer. American Joint Committee on Cancer. 5th edition. Philadelphia: JB Lippincott, 1997.
   Google Scholar
• Roder J. D., Böttcher K., Busch R., Wittekind C., Hermanek P., SlEWERT J. R FOR THE GERMAN GASTRIC CANCER STUDY GROUP. Classification of regional lymph node metastasis from gastric carcinoma. Ann Cancer Soc, 1998, 82: 621–31.
   Google Scholar
• Hayashi H., Ochiai T., Suzuki T. et al. The superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery, 2000, 127: 129–35.
   Google Scholar
• Karpeh M. S., Leon L., Klimstra D., Brennan M. F. Lymph node staging in gastric cancer: is location more important than number ? Ann Surg, 2000, 232: 362–71.
   Google Scholar
• Ichikura T., Tomimatsu S., Uefuji K. et al. Evaluation of the new American Joint Committee on Cancer/international union against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer, 1999, 86: 553–8.
   Google Scholar
• Dent D. M., Madden M. V., Price S. K. A randomised comparison of R1 and R2 gastrectomy for gastric cancer. Br J Surg, 1988, 75: 110–2.
   Google Scholar
• Robertson C. S., Chung S. C. S., Woods S. D. et al. A prospective randomised trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg, 1994, 220: 176–82.
   Google Scholar
• Siewert J. R., Bottcher K., Stein H. J., Roder J. D and the German gastric carcinoma group. Relevant prognostic factors in gastric cancer - ten-year results of the German gastric cancer study. Ann Surg, 1998, 228: 449–61.
   Google Scholar
• Pacelli F., Doglietto G. B., Bellantone R. et al. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg, 1993, 80: 1153–6.
   Google Scholar
• Ikeguchi M., Oka S.-I., Gomyo T. et al. The prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer. Anticancer res, 2000, 20: 1285–90.
   Google Scholar
• Volpe C. M., Driscoll D. L., Douglass H. O. Jr. The outcome of patients with proximal gastric cancer depends on the extent of resection and the number of resected lymph nodes. Ann Surg Onc, 2000, 7: 139–44.
   Google Scholar
• De Manzoni G., Verlato G., Guglielmi A. et al. The prognostic significance of lymph node dissection in gastric cancer. Br J Surg, 1996, 83: 1604–7.
   Google Scholar
• Japanese Research Society for Gastric Cancer. Jpn J Surg, 1981, 11: 127–45.
   Google Scholar
• Lee H. K., Yang H. K., Kim W. H. et al. The influence of the number of lymph nodes examined on the staging of gastric cancer. Br J Surg, 2001, 88: 1408–12.
   Google Scholar
• Giovanetti M., Brotto A. C., Tiberio G. A. et al. D2 lymphecto-my in the treatment of gastric cancer. A retrospective view on our experience, 1990–1996. J Exp Clin Cancer Res, 1999, 18: 455–58.
   Google Scholar
• Degiuli M., Sasako M., Ponti A. et al. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the italian Gastric Cancer Study Group. A prospective multi-centre surgical study. Clin Oncol, 1998, 16: 1490–93.
   Google Scholar
• Kolodziejczyk P., Kulig J., Szczepanik A. et al. The ratio of metastatic to resected lymph nodes is an accurate predictor of survival in patients with inadequately staged gastric cancer. International Surgical Week, ISS-SIC, August 26–30, 2007, Montreal, canada.
   Google Scholar